What is the recommended dose of nitrofurantoin for a 13-year-old patient weighing 36.4kg with a presumed urinary tract infection (UTI) and normal renal function?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 18, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Nitrofurantoin Dosing for a 13-Year-Old, 36.4kg Patient

For this 13-year-old patient weighing 36.4kg with a presumed uncomplicated UTI and normal renal function, nitrofurantoin should be dosed at 5-7 mg/kg/day divided into 4 doses (approximately 45-65 mg four times daily), given for 7 days minimum. 1

Weight-Based Dosing Calculation

  • Standard pediatric dosing: 5-7 mg/kg/day divided into 4 doses, with maximum 100 mg per dose 1
  • For 36.4kg patient:
    • Lower range: 5 mg/kg × 36.4 kg = 182 mg/day (approximately 45 mg four times daily) 1
    • Upper range: 7 mg/kg × 36.4 kg = 254.8 mg/day (approximately 65 mg four times daily) 1
  • Practical dosing: 50 mg four times daily (every 6 hours) is a reasonable middle-ground dose that maintains therapeutic urinary concentrations 1

Treatment Duration and Administration

  • Minimum duration: 7 days for uncomplicated cystitis, continuing at least 3 days after obtaining sterile urine 1
  • Dosing frequency: Four times daily (every 6 hours) is essential to maintain adequate urinary drug concentrations 1
  • Formulation preference: Macrocrystalline or monohydrate/macrocrystalline formulations are preferred for better gastrointestinal tolerability 1

Critical Safety Considerations

  • Renal function verification: Serum creatinine must be normal before initiating therapy, as nitrofurantoin requires adequate urinary excretion for efficacy 1
  • Indication limitation: Nitrofurantoin is approved only for uncomplicated lower UTI (cystitis); it is NOT appropriate for pyelonephritis or perinephric abscess 1
  • Common side effects: Nausea and headache are generally mild 1

Important Clinical Caveats

  • Age consideration: While nitrofurantoin is not formally approved for children under 12 years by some regulatory agencies, it is widely used off-label with established safety data; at 13 years, this patient falls within the approved age range 1
  • Complete the course: Avoid premature discontinuation even if symptoms resolve earlier—ensure the full 7-day minimum course to prevent recurrence 1
  • Alternative agents: If the patient appears toxic, cannot tolerate oral medications, or has suspected pyelonephritis, consider alternative therapy such as amoxicillin-clavulanate (20-40 mg/kg/day divided into 3 doses) or parenteral options 2, 3

Local Resistance Patterns

  • Nitrofurantoin maintains excellent susceptibility (93.3%) against common urinary pathogens in pediatric patients, making it a preferred first-line agent for uncomplicated cystitis 2

References

Guideline

Nitrofurantoin Treatment Guidelines for Pediatric Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Pediatric UTI Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Co-Amoxiclav for Pediatric UTI

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

Do I continue empiric Macrobid (nitrofurantoin) for a urinary tract infection (UTI) in a symptomatic patient with a negative urinalysis?
What is the recommended treatment for a urinary tract infection (UTI)?
Is 5 ml of Nitrofurantoin (25mg/5ml) every 6 hours for 7 days an appropriate treatment for a 38-pound female with a urinary tract infection (UTI)?
Is Macrobid (nitrofurantoin) still appropriate for a patient with a urinary tract infection given the sensitivity report?
Is it appropriate to re-try Nitrofurantoin (antibiotic) for a patient with a history of urinary tract infections (UTIs) who previously experienced reduced efficacy due to a potential interaction with Magnesium (mineral supplement)?
What is the recommended dosing for valsartan (angiotensin II receptor antagonist) in a patient with hypertension or heart failure, considering factors such as age, kidney function, and potential drug interactions?
What are the typical dosing regimens for valsartan and propranolol in a patient with hypertension and potential cardiovascular conditions, considering factors such as age, kidney function, and other health conditions?
What metal use should be avoided in patients undergoing chemotherapy with cisplatin (platinum) or other chemotherapy drugs?
How can pre-excitation be identified on a baseline electrocardiogram (ECG) in a patient with a history of recurrent supraventricular tachycardia (SVT)?
What is the prognosis for an adult patient with a history of neurological symptoms or conditions after undergoing a 4b (fourth ventricle) Magnetic Resonance Imaging (MRI) scan?
What is the recommended dosing for co-therapy with valsartan (angiotensin II receptor antagonist) and propranolol (beta blocker) in a patient with hypertension and no significant contraindications?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.